Report cover image

Next Science Ltd (NXS) - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 04, 2024
Length 26 Pages
SKU # GBDT18719547

Description

Summary


Next Science Ltd (Next Science), formerly Next Science Group Pty Ltd, is a medical technology company. The company develops non-toxic technology products for antimicrobial resistance and bacterial biofilms. Its products include SurgX, an innovative surgical gel designed to reduce superficial surgical site infections (SSIs) and protect wound tissue that facilitates natural healing; and BlastX, an antimicrobial wound gel that destroys bacteria. Next Science commercializes and develops a proprietary Xbio technology, which is a non-toxic technology eradicating biofilm-based and free-floating bacteria and reducing the impact of biofilm-based infections in human health. The company has patented applications across multiple market segments, including over-the-counter medications, prescription pharmaceuticals, medical devices, and hospital infection control. It operates with a research and development center in Florida, the US. Next Science is headquartered in Chatswood, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Next Science Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

26 Pages
Next Science Ltd Company Overview
Next Science Ltd Company Snapshot
Next Science Ltd Pipeline Products and Ongoing Clinical Trials Overview
Next Science Ltd – Pipeline Analysis Overview
Next Science Ltd - Key Facts
Next Science Ltd - Major Products and Services
Next Science Ltd Pipeline Products by Development Stage
Next Science Ltd Ongoing Clinical Trials by Trial Status
Next Science Ltd Pipeline Products Overview
Integrated BlastX Collagen Wound Gel
Integrated BlastX Collagen Wound Gel Product Overview
White Label Version - Xperience
White Label Version - Xperience Product Overview
XPerience Surgical Rinse
XPerience Surgical Rinse Product Overview
XPerience Surgical Rinse Clinical Trial
Next Science Ltd - Key Competitors
Next Science Ltd - Key Employees
Next Science Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Next Science Ltd, Recent Developments
Dec 22, 2023: Next Science : Publication of Knee Study Showing Potential Anti-inflammatory Benefit for XPERIENCE
Nov 03, 2023: Study Finds Infection Prevention Benefit in Periprosthetic Joint Surgery for Xperience Advanced Surgical Irrigation
Jun 29, 2023: Next Science : Market Update
Oct 19, 2022: US Medicare accreditation signals growth in Wound Care revenue
Aug 26, 2022: XPERIENCE cleared for sale in Canada
May 27, 2022: Next Science to strengthen senior leadership presence in US
May 19, 2022: Oraderm Pharmaceuticals appointed as BlastX distributor for Australia and New Zealand
May 10, 2022: New study finds XPERIENCE no rinse solution has persistent efficacy against both planktonic bacteria and bacterial biofilms
Jan 31, 2022: Enhanced sales and distribution relationship with Zimmer Biomet
Nov 08, 2021: NEXT Science: XPERIENCE cleared by TGA for sale in Australia
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Next Science Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Next Science Ltd Pipeline Products by Equipment Type
Table 3: Next Science Ltd Pipeline Products by Indication
Table 4: Next Science Ltd, Key Facts
Table 5: Next Science Ltd, Major Products and Services
Table 6: Next Science Ltd Number of Pipeline Products by Development Stage
Table 7: Next Science Ltd Pipeline Products Summary by Development Stage
Table 8: Next Science Ltd Ongoing Clinical Trials by Trial Status
Table 9: Next Science Ltd Ongoing Clinical Trials Summary
Table 10: Integrated BlastX Collagen Wound Gel - Product Status
Table 11: Integrated BlastX Collagen Wound Gel - Product Description
Table 12: White Label Version - Xperience - Product Status
Table 13: White Label Version - Xperience - Product Description
Table 14: XPerience Surgical Rinse - Product Status
Table 15: XPerience Surgical Rinse - Product Description
Table 16: XPerience Surgical Rinse - Clinical Evaluation of the Rate of Total Joint Infection 90-day after Surgery Following Irrigation with Next Science No-Rinse Solution vs SOC Alone
Table 17: Next Science Ltd, Key Employees
Table 18: Next Science Ltd, Other Locations
Table 19: Next Science Ltd, Subsidiaries
Table 20: Glossary
List of Figures
Figure 1: Next Science Ltd Pipeline Products by Equipment Type
Figure 2: Next Science Ltd Pipeline Products by Development Stage
Figure 3: Next Science Ltd Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us